Director Shareholding

RNS Number:4899V
Innovision Research&Technology PLC
17 February 2004


                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1. Name of company

Innovision Research & Technologyplc

2. Name of director

Mike Wroe

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest

97,500 in respect of shareholder named in 2 above
12,500 in respect of spouse of shareholder named in 2 above

4. Name of the registeredholder(s) and, if more than one holder, the number of
shares held by each of them (if notified)


5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)


6.Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary

Exercise of share options and market sale of resultant shares

7. Number of shares / amount of stock acquired

110,000

8. Percentage of issued class

0.28%

9. Number of shares/amount of stock disposed

110,000

10. Percentage of issued class

0.28%

11. Class of security

Ordinary Shares

12. Price per share

Options exercised at 45p per share
Resultant shares sold at 112.5p per share

13. Date of transaction

16 February 2004

14. Date company informed

16 February 2004

15. Total holding following this notification

10,000

16. Total percentage holding ofissued class following this notification

0.03

If a director has been granted options by the company please complete the
following boxes.

17. Date of grant

...............................................................

18. Period duringwhich or date on which exercisable

...............................................................

19. Total amount paid (if any) for grant of the option

...............................................................

20. Description of shares or debentures involved: class, number

...............................................................

21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise

...............................................................

22. Total number of shares or debentures over which options held following this
notification

...............................................................

23. Any additional information

...............................................................

24. Name of contact and telephone number for queries

Mike Wroe - 0118 979 2000

25. Name and signature of authorised company official responsible for making
this notification

Mike Wroe

Date ofNotification

17 February 2004


The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSTFMRTMMTBBPI